XML 31 R94.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Quarterly Operating Results (unaudited) (Schedule) (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Quarterly Financial Data [Abstract]                      
Net revenues $ 1,926 $ 1,956 $ 1,953 $ 1,891 $ 1,839 $ 1,889 $ 1,919 $ 1,884 $ 7,726 $ 7,531 $ 7,402
Gross profit 662 692 688 647 604 667 676 658 2,689 2,605  
Income from continuing operations 265 226 219 176 139 227 233 189 886 788 824
Income (loss) from discontinued operations, net of taxes 0 0 20 0 0 0 0 0 20 0 0
Net income 265 226 239 176 139 227 233 189 906 788 824
Less: net income attributable to noncontrolling interests 12 11 13 12 12 14 14 12 48 52 52
Net income attributable to Quest Diagnostics $ 253 $ 215 $ 226 $ 164 $ 127 $ 213 $ 219 $ 177 $ 858 $ 736 $ 772
Earnings per share attributable to Quest Diagnostics’ common stockholders - basic:                      
Income from continuing operations (in dollars per share) $ 1.88 $ 1.59 $ 1.52 $ 1.22 $ 0.93 $ 1.56 $ 1.60 $ 1.30 $ 6.21 $ 5.39 $ 5.63
Income from discontinued operations (in dollars per share) 0 0 0.15 0 0 0 0 0 0.15 0 0
Net income (in dollars per share) 1.88 1.59 1.67 1.22 0.93 1.56 1.60 1.30 6.36 5.39 5.63
Earnings per share attributable to Quest Diagnostics’ common stockholders - diluted:                      
Income from continuing operations (in dollars per share) 1.86 1.56 1.51 1.20 0.92 1.53 1.57 1.27 6.13 5.29 5.50
Income from discontinued operations (in dollars per share) 0 0 0.15 0 0 0 0 0 0.15 0 0
Net income (in dollars per share) $ 1.86 $ 1.56 $ 1.66 $ 1.20 $ 0.92 $ 1.53 $ 1.57 $ 1.27 $ 6.28 $ 5.29 $ 5.50